Novo Nordisk A/S
 

Study demonstrates long-term efficacy and safety of NovoLog® Mix 70/30 in type 2 diabetes as compared to biphasic human insulin 30

Contract Partners
Diabetes Education Web Ordering Program

Continuing Education
Available for pharmacists, nurses, and dietitians